AQXP - Aquinox Pharmaceuticals, Inc.
We couldn't determine Recommendation based on the data we have.

Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Aquinox Pharmaceuticals, Inc. (AQXP) -
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada.
Exchange - NASDAQ
Industry - Biotechnology
Sector - Health Technology
CEO - David J. Main
Employees - 8

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.